s 12363 has been researched along with Leukemia L 1210 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atassi, G; Boutin, JA; Hautefaye, P; Lavielle, G; Léonce, S; Pérez, V; Pierré, A; Saint-Dizier, D | 1 |
| Anstett, M; Combe-Perez, V; Leonce, S; Pierre, A | 1 |
2 other study(ies) available for s 12363 and Leukemia L 1210
| Article | Year |
|---|---|
Relationship between the cellular accumulation and the cytotoxicity of S12363, a new Vinca alkaloid derivative.
Topics: Animals; Antineoplastic Agents, Phytogenic; Binding, Competitive; Brain; Cell Line; Chromatography, High Pressure Liquid; Humans; Leukemia L1210; Protein Binding; Tritium; Tubulin; Tumor Cells, Cultured; Vinblastine; Vinca Alkaloids; Vincristine | 1992 |
Flow cytometric evaluation of the cell cycle perturbations induced by S12363, a new vinca alkaloid derivative.
Topics: Acridine Orange; Animals; Benzimidazoles; Cell Cycle; Chromatin; Flow Cytometry; Leukemia L1210; Mice; Mitosis; Thymidine; Tumor Cells, Cultured; Vinblastine; Vinca Alkaloids; Vincristine; Vindesine | 1990 |